Pharmaceutical Industry Information Portal

Pharmasyntez-Nord JSC starts manufacturing the Sputnik Light vaccine developed by Gamaleya Research Center

Investments in the vaccine production are over 2 billion rubles.

The production capacity is about 4 million vaccine doses per month.

When the domestic market is saturated with the vaccine, Pharmasyntez plans to export it to the countries where Sputnik Light has been approved.


Expert Articles